Cryoport Inc. (CKX)
XSTU 
Summary
CKX Chart
Cryoport, Inc. (CYRX) Q3 2025 Earnings Call Transcript
Cryoport, Inc. ( CYRX ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Jerrell Shelton - Chairman, President & CEO Robert Stefanovich - Senior VP, CFO, Treasurer & Chief Administrative Officer Mark W. Sawicki - Senior VP & Chief Scientific Officer Thomas Heinzen - Vice President of Corporate Development & Investor Relations Conference Call Participants Todd Fromer - Kanan, Corbin, Schupak & Aronow, Inc. Kyle Crews - UBS Investment Bank, Research Division David Saxon - Needham & Company, LLC, Research Division Puneet Souda - Leerink Partners LLC, Research Division Matthew Stanton - Jefferies LLC, Research Division Subhalaxmi Nambi - Guggenheim Securities, LLC, Research Division David Larsen - BTIG, LLC, Research Division Mason Carrico - Stephens Inc., Research Division Presentation Operator " Jerrell Shelton Chairman, President & CEO " Robert Stefanovich Senior VP, CFO, Treasurer & Chief Administrative Officer " Mark W.
CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.02 per share a year ago.
Cryoport, Inc. (CYRX) Q2 2025 Earnings Call Transcript
Cryoport, Inc. (NASDAQ:CYRX ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Jerrell W. Shelton - Chairman, President & CEO Mark W.
Cryoport Inc. (CKX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Cryoport Inc. ever had a stock split?
Cryoport Inc. Profile
| Air Freight & Logistics Industry | Industrials Sector | Jerrell W. Shelton CEO | XSTU Exchange | US2290503075 ISIN |
| US Country | 1,090 Employees | - Last Dividend | 19 May 2015 Last Split | 15 Mar 2005 IPO Date |
Overview
Cryoport, Inc. is a pivotal player in the temperature-controlled supply chain industry, specializing in solutions for various sectors including biopharma/pharma, animal health, and human reproductive medicine. The company's reach spans across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, making it a global provider. Established in 1999 and headquartered in Brentwood, Tennessee, Cryoport has carved a niche in offering innovative and reliable logistics and storage solutions tailored for the management of temperature-sensitive biological materials.
Products and Services
- Cryoport Express Shippers: Specialized shipping containers designed for the secure and temperature-controlled transport of biological materials.
- Cryoport ELITE -80°C Gene Therapy Shipper: Advanced shipping solution catering specifically to the gene therapy sector, enabling safe transport at extremely low temperatures.
- Cryoport ELITE Cryosphere Shipper: Another variant in the Cryoport ELITE series, these shippers are tailored for shipping materials that require maintenance of specific cold temperatures without the need for external power sources.
- Cryoport Consulting Services: Offers expertise in the qualification of shipping systems, packaging solutions, and the development of custom packaging to meet client-specific needs across various temperature ranges.
- Cryoport Bioservices: Comprehensive suite of services including controlled temperature storage, fulfilment, secondary packaging, and labelling of therapeutic products, alongside GMP raw materials storage services.
- CRYOGENE Services: Specialized in the management of pre-clinical temperature-controlled biological materials encompassing specimen storage, collection, and retrieval processes.
- CRYOPD: Offers a range of temperature-controlled logistics solutions ranging from cryogenic to controlled ambient packaging and transport solutions.
- IntegriCell Services: Focuses on services like apheresis/leukapheresis collection, Cryoshuttle transportation, and cryo-process optimization, catering to the cell and gene therapy sectors.
- MVE Biological Solutions' Fusion Cryogenic System: A self-sustaining cryogenic freezer designed for the secure storage of biological specimens at ultra-low temperatures.
- MVE Biological Solutions' Vario Cryogenic System: Offers flexible temperature management between -20°C and -150°C, addressing a broad spectrum of cryogenic storage needs.
- Cryoport Cryoshuttle: Provides dedicated local transportation support, enhancing the delivery and receipt of sensitive biological materials.
- Tec4Med: Although not elaborated upon, it is indicated as part of Cryoport’s suite of solutions, likely representing a technology-driven service or product within the logistics and cryogenic storage domain.
- Additional Services: Cryoport also offers an array of supplementary services including biological specimen cryopreservation, archiving, monitoring, tracking, receipt, delivery management of samples, and logistics and engineering consulting services.
Contact Information
